Abstract:Hepatocellular carcinoma (HCC) is one of the deadliest cancers worldwide due to the lack of effective therapy methods. Therefore, there is an urgent need to develop novel therapies for HCC. CBL0137 is a small molecule that affects p53 and nuclear factor-kappa B (NF-κB). The expression of p53 was measured by using immunohistochemistry (IHC) in tumor and adjacent tissues. Western blotting (WB) and quantitative real-time polymerase chain reaction (qRT-PCR) were employed to detect the level of p-p53, p53, Bax, and PUMA after CBL0137 administration. CCK-8 and immunofluorescence staining (IF) assays were performed to evaluate the proliferation and viability of HCC cells. Flow cytometry was used to detect the apoptosis of HCC cells. Xenograft model was established to determine the effect of CBL0137 treatment on HCC tumor growth in vivo. HE staining was used to monitor HCC cell morphology and IHC staining for Ki-67 was performed to determine the tumor cell proliferation following CBL0137 treatment. Results showed that the expression of p-p53, p53, Bax, and PUMA was upregulated after CBL0137 administration. The viability, growth, and colony formation of HCC cells were significantly inhibited by CBL0137 in the CBL group compared with the NC group (p<0.05). Meanwhile, the results revealed that the proportions of apoptotic and necrotic cells were significantly elevated in the CBL group compared to the NC group (p<0.05). And the apoptosis-related proteins including PARP, caspase-3, caspase-7, caspase-8, and caspase-9 were increased in the CBL group compared with the NC group (p<0.05), while the NF-κB, p-NF-κB and p-AKT expression levels were significantly downregulated following CBL0137 treatment (p<0.05). Additionally, the tumor volume and weight were significantly reduced in the CBL group compared with the NC group (p<0.05). Moreover, HE staining and IHC staining for Ki-67 indicated that CBL0137 treatment could obviously induce cell apoptosis and suppress cell proliferation. CBL0137 treatment could effectively inhibit HCC cell proliferation and induce cell apoptosis associated with multiple factors expression.

Apoptosis of Human Hepatoma Cell Lines Induced by Transforming Growth Factor Beta 1 (Tgf-Beta1) Correlates with P53 and Smad4 Activation.

TGF-beta1/SMAD signaling pathway mediates p53-dependent apoptosis in hepatoma cell lines.

Study of Mechanism of Apoptotic Signal Transduction in Human Hepatic Carcinoma Cell Lines Induced by TGF-β1

Study on TGF-β1-mediated Apoptosis of Human Hepatoma Cell Lines

STAT1 Inhibits Human Hepatocellular Carcinoma Cell Growth Through Induction of P53 and Fbxw7

Change From Promotion To Inhibition On Apoptosis In Hepatoma Cells Transferred Wild-Type P53 Gene

Identification Of The Gene Transcription And Apoptosis Mediated By Tgf-Beta-Smad2/3-Smad4 Signaling

Transforming Growth Factor-1 Downregulation of Smad 1 Gene Expression in Rat Hepatic Stellate Cells

TGF-β Signaling is Often Attenuated During Hepatotumorigenesis, but is Retained for the Malignancy of Hepatocellular Carcinoma Cells.

CBL0137 Administration Suppresses Human Hepatocellular Carcinoma Cells Proliferation and Induces Apoptosis Associated with Multiple Cell Death Related Proteins.

Upregulation Of Mir-23a Similar To 27a Similar To 24 Decreases Transforming Growth Factor-Beta-Induced Tumor-Suppressive Activities In Human Hepatocellular Carcinoma Cells

Smad2/3/4 complex could undergo liquid liquid phase separation and induce apoptosis through TAT in hepatocellular carcinoma

Constitutively Active PKB/Akt Inhibited Apoptosis and Down-Regulated Β1,4-Galactosyltransferase 1 in Hepatocarcinoma Cells

Pim-2 Activates API-5 to Inhibit the Apoptosis of Hepatocellular Carcinoma Cells Through NF-κB Pathway

Upregulation of miR-23a approximately 27a approximately 24 decreases transforming growth factor-beta-induced tumor-suppressive activities in human hepatocellular carcinoma cells.

Influence of Apoptin on Up-Regulation of the Expression of Bad and Bax

Hepatocytes Treated With Hbv X Protein As Cytotoxic Effectors Kill Primary Hepatocytes By Tnf-Alpha-Related Apoptosis-Induced Ligand-Mediated Mechanism

Smad Proteins And Hepatocyte Growth Factor Control Parallel Regulatory Pathways That Converge On Beta 1-Integrin To Promote Normal Liver Development

Effects of Recombinant Human Adenovirus-P53 on the Regression of Hepatic Fibrosis

Transforming Growth Factor-β1 (TGF-β)–induced Apoptosis of Prostate Cancer Cells Involves Smad7-dependent Activation of p38 by TGF-β-activated Kinase 1 and Mitogen-activated Protein Kinase Kinase 3

Smad Protein Mediated Transforming Growth Factor Β1 Induction of Apoptosis in the MDPC-23 Odontoblast-Like Cell Line